-
Je něco špatně v tomto záznamu ?
LIM and SH3 protein 2 (Lasp2) is a novel pregnane X receptor target gene in mouse liver
A. Konzack, M. Karpale, T. Smutny, M. Hassanen, P. Lassila, MH. Ahonen, MS. Elkhwanky, O. Kummu, P. Pavek, J. Hakkola
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
NLK
Open Access Digital Library
od 1965-07-01
Open Access Digital Library
od 1997-01-01
ROAD: Directory of Open Access Scholarly Resources
- MeSH
- adaptorové proteiny signální transdukční genetika metabolismus MeSH
- cytoskeletální proteiny * genetika metabolismus MeSH
- hepatocyty metabolismus účinky léků MeSH
- játra * metabolismus účinky léků MeSH
- lidé MeSH
- myši inbrední C57BL * MeSH
- myši knockoutované * MeSH
- myši MeSH
- pregnanový X receptor * genetika metabolismus MeSH
- pregnenolonkarbonitril farmakologie MeSH
- proteiny s doménou LIM * genetika metabolismus MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- myši MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
LIM and Src homology 3 (SH3) protein 2 (LASP2) is a small focal adhesion protein first identified as a splice variant of the nebulette gene (Nebl). As the newest member of the nebulin protein family, the regulation and function of LASP2 remain largely unknown. Our previous RNA-sequencing results identified Nebl as one of the most highly induced genes in the mouse liver in response to the activation of pregnane X receptor (PXR). In this study, we investigated this phenomenon further and show that PXR induces Lasp2 instead of Nebl, which partially use the same exons. Lasp2 was found to be induced in response to PXR ligand pregnenolone 16α-carbonitrile (PCN) treatment in mouse liver in vivo both after 4-day treatment and after long-term, 28-day treatment and in both male and female mice. Interestingly, the Lasp2 induction was more efficient in high-fat diet-fed mice (103-fold after 4-day PCN treatment) than in the normal chow-fed mice (32-fold after 4-day PCN treatment). Lasp2 induction was abolished in PXR knockout mice but could be rescued by re-expression of PXR, indicating that Lasp2 induction is PXR mediated. In mouse primary hepatocytes cycloheximide did not inhibit Lasp2 induction by PCN and a PXR binding site could be recognized upstream of the mouse Lasp2 gene suggesting direct regulation of Lasp2 by PXR. In human 3D hepatocytes, rifampicin induced only a modest increase in LASP2 expression. This study shows for the first time that PXR activation strongly induces Lasp2 expression in mouse liver and establishes Lasp2 as a novel PXR target gene. SIGNIFICANCE STATEMENT: RNA-sequencing results have previously identified nebulette (Nebl) to be efficiently induced by pregnane X receptor activating compounds. This study shows that instead of Nebl, LIM and Src homology 3 (SH3) protein 2 (Lasp2) coding for a small focal adhesion protein and partly sharing exons with the Nebl gene is a novel target of pregnane X receptor in mouse liver.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25009617
- 003
- CZ-PrNML
- 005
- 20250429134735.0
- 007
- ta
- 008
- 250415s2025 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.molpha.2025.100019 $2 doi
- 035 __
- $a (PubMed)40023092
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Konzack, Anja $u Research Unit of Biomedicine and Internal Medicine, Biocenter Oulu, Medical Research Center Oulu, University of Oulu and Oulu University Hospital, Oulu, Finland
- 245 10
- $a LIM and SH3 protein 2 (Lasp2) is a novel pregnane X receptor target gene in mouse liver / $c A. Konzack, M. Karpale, T. Smutny, M. Hassanen, P. Lassila, MH. Ahonen, MS. Elkhwanky, O. Kummu, P. Pavek, J. Hakkola
- 520 9_
- $a LIM and Src homology 3 (SH3) protein 2 (LASP2) is a small focal adhesion protein first identified as a splice variant of the nebulette gene (Nebl). As the newest member of the nebulin protein family, the regulation and function of LASP2 remain largely unknown. Our previous RNA-sequencing results identified Nebl as one of the most highly induced genes in the mouse liver in response to the activation of pregnane X receptor (PXR). In this study, we investigated this phenomenon further and show that PXR induces Lasp2 instead of Nebl, which partially use the same exons. Lasp2 was found to be induced in response to PXR ligand pregnenolone 16α-carbonitrile (PCN) treatment in mouse liver in vivo both after 4-day treatment and after long-term, 28-day treatment and in both male and female mice. Interestingly, the Lasp2 induction was more efficient in high-fat diet-fed mice (103-fold after 4-day PCN treatment) than in the normal chow-fed mice (32-fold after 4-day PCN treatment). Lasp2 induction was abolished in PXR knockout mice but could be rescued by re-expression of PXR, indicating that Lasp2 induction is PXR mediated. In mouse primary hepatocytes cycloheximide did not inhibit Lasp2 induction by PCN and a PXR binding site could be recognized upstream of the mouse Lasp2 gene suggesting direct regulation of Lasp2 by PXR. In human 3D hepatocytes, rifampicin induced only a modest increase in LASP2 expression. This study shows for the first time that PXR activation strongly induces Lasp2 expression in mouse liver and establishes Lasp2 as a novel PXR target gene. SIGNIFICANCE STATEMENT: RNA-sequencing results have previously identified nebulette (Nebl) to be efficiently induced by pregnane X receptor activating compounds. This study shows that instead of Nebl, LIM and Src homology 3 (SH3) protein 2 (Lasp2) coding for a small focal adhesion protein and partly sharing exons with the Nebl gene is a novel target of pregnane X receptor in mouse liver.
- 650 _2
- $a zvířata $7 D000818
- 650 12
- $a pregnanový X receptor $x genetika $x metabolismus $7 D000077297
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a játra $x metabolismus $x účinky léků $7 D008099
- 650 12
- $a proteiny s doménou LIM $x genetika $x metabolismus $7 D060588
- 650 12
- $a cytoskeletální proteiny $x genetika $x metabolismus $7 D003598
- 650 12
- $a myši inbrední C57BL $7 D008810
- 650 12
- $a myši knockoutované $7 D018345
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a pregnenolonkarbonitril $x farmakologie $7 D011285
- 650 _2
- $a adaptorové proteiny signální transdukční $x genetika $x metabolismus $7 D048868
- 650 _2
- $a hepatocyty $x metabolismus $x účinky léků $7 D022781
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Karpale, Mikko $u Research Unit of Biomedicine and Internal Medicine, Biocenter Oulu, Medical Research Center Oulu, University of Oulu and Oulu University Hospital, Oulu, Finland
- 700 1_
- $a Smutny, Tomas $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University, Czech Republic
- 700 1_
- $a Hassanen, Mohamed $u Research Unit of Biomedicine and Internal Medicine, Biocenter Oulu, Medical Research Center Oulu, University of Oulu and Oulu University Hospital, Oulu, Finland
- 700 1_
- $a Lassila, Piia $u Research Unit of Biomedicine and Internal Medicine, Biocenter Oulu, Medical Research Center Oulu, University of Oulu and Oulu University Hospital, Oulu, Finland
- 700 1_
- $a Ahonen, Maria H $u Research Unit of Biomedicine and Internal Medicine, Biocenter Oulu, Medical Research Center Oulu, University of Oulu and Oulu University Hospital, Oulu, Finland
- 700 1_
- $a Elkhwanky, Mahmoud-Sobhy $u Research Unit of Biomedicine and Internal Medicine, Biocenter Oulu, Medical Research Center Oulu, University of Oulu and Oulu University Hospital, Oulu, Finland
- 700 1_
- $a Kummu, Outi $u Research Unit of Biomedicine and Internal Medicine, Biocenter Oulu, Medical Research Center Oulu, University of Oulu and Oulu University Hospital, Oulu, Finland
- 700 1_
- $a Pavek, Petr $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University, Czech Republic
- 700 1_
- $a Hakkola, Jukka $u Research Unit of Biomedicine and Internal Medicine, Biocenter Oulu, Medical Research Center Oulu, University of Oulu and Oulu University Hospital, Oulu, Finland. Electronic address: jukka.hakkola@oulu.fi
- 773 0_
- $w MED00003399 $t Molecular pharmacology $x 1521-0111 $g Roč. 107, č. 3 (2025), s. 100019
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/40023092 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250415 $b ABA008
- 991 __
- $a 20250429134730 $b ABA008
- 999 __
- $a ok $b bmc $g 2311159 $s 1246698
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 107 $c 3 $d 100019 $e 20250207 $i 1521-0111 $m Molecular pharmacology $n Mol Pharmacol $x MED00003399
- LZP __
- $a Pubmed-20250415